Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What is the Expected Growth Rate of the Intravenous Immunoglobulin Market for the Period 2024 to 2033?

The size of the intravenous immunoglobulin market has experienced significant growth in the recent past. It is forecasted to rise from $13.82 billion in 2023 to $14.84 billion in 2024, indicating a compound annual growth rate (CAGR) of 7.3%. The impressive growth in the historic period was fueled by factors such as the treatment of primary immunodeficiency disorders, neurology management, a growing elderly population, advancements in plasma fractionation techniques, increased neurology indications, infection treatment, and pediatric immunodeficiency treatment.

In the upcoming years, the intravenous immunoglobulin market is set to experience robust expansion, with predictions pointing towards a growth to $20.24 billion in 2028, marking a compound annual growth rate (CAGR) of 8.1%. Factors anticipated to fuel growth during the forecast period include the rising incidences of autoimmune disorders, ongoing immunology research, increased healthcare spending, the escalating incidences of cancer, as well as innovations in immunoglobulin products and the application of personalized medicine approaches. Noteworthy trends forecasted for this period encompass treatment for primary immunodeficiency disorders (pidd), swift technological advancements, strategic alliances and partnerships, progress in manufacturing methods, neurological indications, usage in haematology, and strides in immunotherapy.

Claim Your Free Sample of the Global Intravenous Immunoglobulin Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=8538&type=smp

What Factors Are Responsible for the Growth of the intravenous immunoglobulin Market?

The rise in the geriatric populace is predicted to serve as a catalyst for the progress of the intravenous immunoglobulin market. Those who belong to the geriatric demographic are individuals over 65 years of age. The immune system of elderly people doesn’t function optimally and there is a shortage of antibodies. Hence, they require immunoglobulins for antibody supplementation. This boosts the demand for intravenous immunoglobulins, promoting the growth of the intravenous immunoglobulin market. For instance, the National Statistical Office’s (NSO) 2021 Elderly in India report specifies that in 2021, India had 138 million senior citizens, a figure that’s projected to go up to 194 million by 2031. Furthermore, the World Health Organization (WHO), a body of the United Nations, anticipates that one-sixth of the global population will be over 60 by 2030 and that the total count of people above 60 will rise from 1 billion in 2020 to 1.4 billion in 2030. Hence, the augmenting elderly population will aid in pushing the intravenous immunoglobulin market.

Which Segments Are Important for Insight into the Intravenous Immunoglobulin Market?

1) By Type: IgG (Immunoglobulin G), IgM (Immunoglobulin M), IgA (Immunoglobulin A), IgE (Immunoglobulin E), IgD (Immunoglobulin D)

2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels

3) By Application: Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Primary Immunodeficiency Diseases, Myasthenia Gravis, Multifocal Motor Neuropathy, Other Applications

4) By End-User: Hospitals, Clinics, Home Care

What Are the Significant Trends Reshaping the Intravenous Immunoglobulin Sector?

The intravenous immunoglobulin market is experiencing an increase in product innovation as a leading trend, with key companies concentrating on the creation of novel products like human plasma-derived intravenous immunoglobulin (IVIg) to treat rare diseases and uphold their market standing. As a case in point, in June 2021, Octapharma, a Swiss pharmaceutical company, proclaimed that their new product called ‘Octagam 10%’, an IVIg sourced from human plasma, got an endorsement from the European Union (EU) as an immunotherapy for adults suffering from dermatomyositis, and also received a national approval from Germany for the same use. This makes Octagam 10% the pioneering therapy approved for treating dermatomyositis in the EU, specifically for adults using immunosuppressive drugs to treat active dermatomyositis. This groundbreaking product holds the potential to better the lives of those affected by dermatomyositis, a rare, unexplained autoimmune disorder.

Order Now for Fast Delivery of Your Intravenous Immunoglobulin Market Report!

https://www.thebusinessresearchcompany.com/report/intravenous-immunoglobulin-global-market-report

North America was the largest region in the intravenous immunoglobulin market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous immunoglobulin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Intravenous Immunoglobulin Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the intravenous immunoglobulin market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Intravenous Immunoglobulin Market Include

1. Intravenous Immunoglobulin Market Executive Summary

2. Intravenous Immunoglobulin Market Segments

3. Intravenous Immunoglobulin Market Size And Template Market Growth Rate

4. Key Intravenous Immunoglobulin Market Trends

5. Major Intravenous Immunoglobulin Market Drivers

……

25. Key Mergers And Acquisitions In The Intravenous Immunoglobulin Market

26. Top Intravenous Immunoglobulin Companies

27. Intravenous Immunoglobulin Market Opportunities And Strategies

28. Intravenous Immunoglobulin Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

Immunoglobulins Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/customer-analytics-global-market-report

Immunosuppressants Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/immunosuppressant-global-market-report

Immunofluorescence Assay Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/immunofluorescence-assay-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: